teneligliptin
Teneligliptin (INN; trade name Tenelia) is a pharmaceutical drug for the treatment of type 2 diabetes mellitus. It belongs to the class of anti-diabetic drugs known as dipeptidyl peptidase-4 inhibitors or "gliptins".
Chemical data
- Formula
- C22H30N6OS
- Molecular weight
- 426.6 g/mol
- IUPAC name
- [(2S,4S)-4-[4-(5-methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone
via PubChem
Article
5 sectionsContents
- Creation
- Licensing and use
- Japan/Korea/India/Argentina
- Pharmacology
- References
{{Drugbox | drug_name = | IUPAC_name = {(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl}(1,3-thiazolidin-3-yl)methanone | image = Teneligliptin.svg | image_class = skin-invert-image | alt = | caption =
| tradename = Tenelia | Drugs.com = | MedlinePlus = | pregnancy_AU = | pregnancy_US = | pregnancy_category= | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = Approved in Japan | routes_of_administration =